Physician profile
Andrew J Diamond
NPI 1114905379
$1,720.67
in general payments reported to CMS, 2019-2025
12 companies · $255 in 2025
The $255 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $407 · 2020: $139 · 2021: $189 · 2022: $69.92 · 2023: $65.62 · 2024: $596 · 2025: $255.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $843 · Education: $73.72.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $842.98 |
| Education | $73.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aerin Medical INC. | $441.81 | 2019-2025 | |
| Intersect Ent, INC. | $391.67 | 2019-2021 | |
| Regeneron Healthcare Solutions, INC. | $364.21 | 2023-2025 | Dupixent |
| Aroa Biosurgery Incorporated | $114.12 | 2022-2024 | |
| Glaxosmithkline, LLC. | $77.46 | 2024-2025 | Nucala |
| Polynovo North America LLC | $71.34 | 2023-2024 | Novosorb Btm |
| Optinose US, INC. | $59.03 | 2019-2024 | |
| Depuy Synthes Sales INC. | $49.13 | 2021 | |
| Acclarent, INC | $48.45 | 2021-2022 | |
| Access Pro Medical, LLC | $41.12 | 2025 | Matriderm |
| Stryker Corporation | $37.07 | 2019 | |
| Ambu INC. | $25.26 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Diamond listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.